通经导气针刺法治疗缺血性脑卒中后上肢痉挛效果分析

Analysis of the Therapeutic Effect of Tongjing Daoqi Acupuncture on Upper Limb Spasm after Ischemic Stroke

目的:分析通经导气针刺法在缺血性脑卒中后上肢痉挛治疗中的运用价值,以促进该传统中医技术在缺血性脑卒中后上肢痉挛患者群体中的普及与推广应用。方法:将2018年9月-2019年12月笔者所在医院收治的80例缺血性脑卒中后上肢痉挛患者随机分组,对照组40例予以常规针刺治疗,治疗组40例予通经导气针刺法治疗,两组均按照每穴留针30 min、1次/d、5 d/周的频率持续治疗4周。对比两组疗效、上肢功能SFMA评分。结果:治疗组治疗总有效率为95.00%,高于对照组,差异有统计学意义(χ2=4.110,P<0.05);治疗组接受治疗后SFMA评分为(30.9±1.7)分,高于对照组,差异有统计学意义(t=27.362,P<0.05)。结论:缺血性脑卒中后上肢痉挛治疗中,相对于常规针刺治疗而言,通经导气针刺法的作用效果更加显著,其可经通经导气、濡养经脉作用,有效解除缺血性脑卒中患者的上肢痉挛状态,重建上肢功能,减轻缺血性脑卒中患者的痛苦体验。

Objective:To analyze the application value of Tongjing Daoqi acupuncture in the treatment of upper limb spasm after ischemic stroke,so as to promote the popularization and application of the traditional Chinese medicine technology in patients with upper limb spasm after ischemic stroke.Method:From September 2018 to December 2019,80 patients with upper limb spasm after ischemic stroke were randomly divided into the control group (40 cases) and the treatment group (40 cases).The control group was treated with conventional acupuncture,and the treatment group was treated with Tongjing Daoqi acupuncture.The two groups were treated continuously for 4 weeks at the frequency of 30 min,1 time/d and 5 days/week for each acupuncture point.The curative effect and SFMA score of upper limb function were compared between the two groups.Result:The total effective rate in the treatment group was 95.00%,higher than that in the control group,the difference was statistically significant (χ~2=4.110,P<0.05).After treatment,the SFMA score in the treatment group was (30.9±1.7) points,higher than that in the control group,the difference was statistically significant (t=27.362,P<0.05).Conclusion:In the treatment of upper limb spasm after ischemic stroke,compared with the conventional acupuncture treatment,the effect of Tongjing Daoqi acupuncture is more significant,which can effectively relieve the upper limb spasticity of patients with ischemic stroke,reconstruct the upper limb function,and relieve the pain experience of patients with ischemic stroke.